https://www.kwtx.com/content/news/New-treatment-offers-promise-of-relief-for-migraine-sufferers-509340081.html
CGRP antagonist
Biohaven Announces Completion of Pre-NDA Meeting With FDA for Oral CGRP Receptor Antagonist Rimegepant, “novel and differentiated treatment option to patients suffering from migraine”
https://www.prnewswire.com/news-releases/biohaven-announces-completion-of-pre-nda-meeting-with-fda-for-oral-cgrp-receptor-antagonist-rimegepant-300811442.html